Profile
SNOA TAK ZTS HLN TEVA VTRS
Company Name Sonoma Pharmaceuticals, Inc. Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $5.15M $56.52B $56.15B $49.48B $39.78B $14.94B
Employees 0.01K 49.28K 13.80K 24.56K 37.00K 32.00K
CEO Amy Trombly Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
SNOA TAK ZTS HLN TEVA VTRS
Quant Rating Score 2 3 3 4 3 2
Quant Rating Sell Neutral Neutral Buy Neutral Sell
Trading
SNOA TAK ZTS HLN TEVA VTRS
Last Close $3.62 $14.14 $118.8 $9.68 $24.59 $10.66
High 52 $5.35 $15.52 $178.71 $11.41 $25.83 $13.37
Low 52 $1.88 $12.89 $118.8 $8.73 $12.82 $7.26
Price vs. 52 Week High -32.34 % -8.89 % -33.52 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 92.55 % 9.7 % 0 % 10.88 % 91.81 % 46.83 %
Total Return
SNOA TAK ZTS HLN TEVA VTRS
1 Month Return -5.48 % 0.71 % -17.53 % 2.11 % 27.34 % 4.82 %
3 Month Return -32.34 % -6.73 % -21.96 % -0.05 % 36.16 % 0.28 %
6 Month Return 12.07 % 0.21 % -27.13 % -10.37 % 45.16 % 20.59 %
9 Month Return 44.8 % 1.73 % -24.08 % -3.1 % 48.4 % -1.84 %
YTD Return 34.57 % 6.8 % -27.09 % 1.47 % 11.57 % -14.38 %
1 Year Return 14.56 % 3.82 % -32.33 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SNOA TAK ZTS HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 3.6 % 1.59 % 1.41 % - 3.7 %
Dividend Paid and Capex Coverage Ration (TTM) -6.58 % 2.23 % 1.89 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 198 % 2.03 % 0.06 % - 0.48 %
Payout Ratio (TTM) - 277.04 % 32.55 % 27.27 % - -15.34 %
Profitability
SNOA TAK ZTS HLN TEVA VTRS
Gross Profit Margin TTM 37.68 % 59.49 % 70.63 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM -25.11 % 0.73 % 17.49 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM -81.27 % 1.58 % 53.56 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM -32.71 % 3.59 % 26.48 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 101.73 % 54.99 % 79.59 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 109.65 % 44.75 % 94.2 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM -18.42 % 10.28 % 37.63 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM -222.62 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 6.27 5.89 6.1 5.14 4.68 3.94
Payables Turnover TTM 7.52 3.87 6.73 1.18 3.31 6.81
Inventory Turnover TTM 2.9 1.29 1.12 3.72 2.63 2.2
Fixed Asset Turnover TTM 2219.79 % 214.23 % 241.44 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 122.24 % 28.97 % 61.99 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM -0.72 710.55 6.58 0.11 1.76 1.7
Free Cash Flow Per Share TTM -0.83 589.53 5.06 0.1 1.32 1.37
Cash Per Share TTM 184.39 % 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM -7.03 % 25.14 % 31.03 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 115.2 % 82.97 % 76.82 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM -222.62 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM -3.76 9.34 25.07 38.08 25.95 9.34
Price To Operating Cash Flows Ratio TTM -4.19 7.75 19.35 35.1 19.5 7.62
Price Cash Flow Ratio TTM -4.19 7.75 19.35 35.1 19.5 7.62
Income Statement (TTM)
SNOA TAK ZTS HLN TEVA VTRS
Revenue $0.01B $4581.55B $9.26B $11.23B $17.26B $14.74B
Gross Profit $0.01B $3001.33B $6.4B $6.95B $8.94B $5.62B
Gross Profit Ratio 38.25% 65.51% 69.1% 61.85% 51.79% 38.15%
EBITDA $-0B $1210.51B $3.87B $2.51B $3.14B $2.82B
Net Income $-0B $107.93B $2.49B $1.44B $1.41B $-0.63B
EPS Diluted -2.79 33.62 5.47 0.32 1.2 -0.53
Balance Sheet (MRQ)
SNOA TAK ZTS HLN TEVA VTRS
Long Term Debt $0B $3966.33B $5.39B $8.62B $15.56B $14.22B
Total Liabilities $0.01B $7312.37B $9.47B $18.09B $32.83B $22.87B
Total Equity $0B $6935.98B $4.77B $16.22B $7.91B $18.64B
Total Investments $0B $382.4B $0.03B $0.14B $0B $1.7B
Total Debt $0B $4515.27B $6.74B $10.1B $17.38B $14.31B
Total Assets $0.01B $14248.34B $14.24B $34.32B $40.75B $41.5B
Cash Flow Statement (TTM)
SNOA TAK ZTS HLN TEVA VTRS
Net Income $-0B $107.93B $2.5B $1.44B $1.42B $-0.63B
Inventory $-0B $-34.97B $-0.04B $0.22B $0.15B $-0.72B
Dividends Paid $0B $-302.5B $-0.79B $-0.57B $0B $-0.57B
Operating Cash Flow $-0B $1057.18B $2.95B $2.3B $1.65B $2.3B
Capital Expenditure $-0B $-200.8B $-0.66B $-0.25B $-0.5B $-0.33B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.48
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.96
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 5.12
ALVOW Alvotech 0.4511
AMPH Amphastar Pharmaceuticals, Inc. 29.26
AMRX Amneal Pharmaceuticals, Inc. 14.52
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 81.84
APUS Apimeds Pharmaceuticals US, Inc 1.62
AQST Aquestive Therapeutics, Inc. 4.11
ASRT Assertio Holdings, Inc. 12.74
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.69
ETFs With Exposure to SNOA
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 151.14
VXF Vanguard Extended Market Index Fund 0.00008 217.96
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00008 165.43
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00008 165.44
VEMPX Vanguard Extended Market Index InstlPlus 0.00008 408.25
Unlock